Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 206006
Company: RISING PHARMS
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,30MG CAPSULE; CAPSULE, DELAYED REL PELLETS; TABLET;ORAL Prescription AB No Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
10/07/2016 ORIG-1 Approval STANDARD

Label is not available on this site.

LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN

CAPSULE; CAPSULE, DELAYED REL PELLETS; TABLET;ORAL; 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,30MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,30MG CAPSULE; CAPSULE, DELAYED REL PELLETS; TABLET;ORAL Prescription No AB 206006 RISING PHARMS

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English